About us

We develop next-generation
catheters that enhance patient care
and create value for society.

About us

Designed for Life

Nowwell is a Medtech company developing next-generation catheters for people living with incontinence and retention. Through scientific excellence and close collaboration with healthcare professionals, we create catheter solutions that set new standards in urology care. Every solution we deliver reflects our commitment to quality, safety, and meaningful clinical impact.
Our Approach

Clinical understanding.
Scientific excellence.
Meaningful impact.

01

Research & Development

We develop next-gen urinary catheters focusing on patient safety, comfort, and clinical needs. Our experienced R&D team explores new technologies and materials to improve the quality of life for patients worldwide.

Research and development
02

Clinical Evidence

We collaborate with leading healthcare professionals to ensure that every catheter we develop is safe, effective, and backed by evidence-based research.

03

Partnerships

We believe in strong partnerships. Working closely with industry leaders, healthcare providers, and urological institutions, we accelerate innovation and bring better catheters to patients and caregivers.

Healthcare partnerships

Our Story

It started with someone close

It began with a grandfather, a routine procedure and an unexpected outcome. It became a loss of comfort, dignity and independence.

What if there
is a better way?

The experience revealed a broader challenge. Despite their widespread use, urinary catheters have seen limited fundamental change - leaving important needs in everyday care unaddressed.

A reason to
move forward

Nowwell was founded to rethink the urinary catheter from the ground up. Independent in our thinking. Scientific in our approach. Collaborative by nature.

The Purpose
behind our work

Enhancing dignity and quality of life for people affected by urinary incontinence and retention.

That purpose guides every solution we develop - for the people who depend on them and the healthcare professionals who provide their care.

NowCath Foley

Designed to address residual urine.
Now being evaluated in the REDUCE clinical trial.